Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke


Phase 1 Results N/A

Trial Description

The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with chronic stroke.



  • Autologous bone marrow mononuclear cell transplantation Biological
    Intervention Desc: bone marrow derived mononuclear cells are administered intrathecally in chronic stroke patients
    ARM 1: Kind: Experimental
    Label: Stem Cells
    Description: autologous bone marrow mononuclear cell transplantation

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment


Type Measure Time Frame Safety Issue
Primary Functional Independence Measure 6 months No